Recent Blog Articles
How — and why — to fit more fiber and fermented food into your meals
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Prostate Health Archive
Articles
A patient’s story: Why one man chose robotic-assisted laparoscopic prostatectomy
After talking with numerous medical professionals and asking friends about how they treated their prostate cancers, financial services executive Steve Henley opted to have a robotic-assisted laparoscopic prostatectomy. In this interview, he explains what factors went into that decision.
Drug combo better at easing BPH than either drug alone
Study shows that taking both dutasteride (Avodart) and tamsulosin (Flomax) might be more effective at easing symptoms than taking just one.
Continuous vs. intermittent hormone therapy (IHT): No survival difference
Given the beneficial effects and the lack of a survival difference, intermittent hormone therapy may be a preferred regimen for men with advanced prostate cancer.
Use caution with selenium supplements
High levels of selenium in the blood are associated with a slightly higher-than-normal risk of aggressive prostate cancer.
Hormone therapy: How long should it last?
A European study finds that mortality is higher among men who pursue hormone therapy for just six months. But the study was conducted in men with relatively large tumors, not small, early-stage tumors, the kind found most often in American men.
Midlife PSA tests may predict prostate cancer diagnosis up to 25 years later
According to a 2007 Swedish study, a PSA test done between the ages of 44 and 50 may predict whether or not a man will develop prostate cancer later in life.
Initial PSA tests can’t distinguish lethal prostate cancers
In a study of over 250 men, Swedish researchers found that neither the initial PSA level nor its rate of increase in a two-year period predicted which men had lethal versus indolent cancers.
PSA screening: What doctors tell their patients
Fifteen Harvard-affiliated physicians discuss their recommendations for PSA screening.
Task force says no to PSA screening for older men
The U.S. Preventive Services task force announced in 2008 that doctors should stop testing men who are 75 or older. The panel also concluded that the benefit of screening in younger men is uncertain.
What does a fluctuating PSA mean?
If your PSA has varied greatly and biopsies have been negative, you might want to try a different testing regimen.
Recent Blog Articles
How — and why — to fit more fiber and fermented food into your meals
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up